Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Department of Radiation Oncology (2)
- Humans (2)
- Thomas Jefferson University (2)
- 80 and over (1)
- 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) (1)
-
- Aged (1)
- Aged, 80 and over (1)
- Annual report (1)
- Antineoplastic Combined Chemotherapy Protocols (1)
- Brain (1)
- Brain Neoplasms/radiotherapy (1)
- Brain Neoplasms/surgery (1)
- Carboplatin (1)
- Carcinoma (1)
- Carcinoma, Non-Small-Cell Lung (1)
- Chicago (1)
- Combined Modality Therapy (1)
- Computer aided diagnosis (1)
- Coronary CTA (1)
- Coronary heart disease (1)
- Coronary stenosis (1)
- Department of Medical Oncology (1)
- Department of Neurosurgery (1)
- Department of Radiology (1)
- Department of radiology (1)
- Disease Progression (1)
- Dose-Response Relationship (1)
- Dose-Response Relationship, Drug (1)
- Drug (1)
- Emergency medicine (1)
Articles 1 - 6 of 6
Full-Text Articles in Radiology
Value-Added Services Of Hospital-Based Radiology Groups, Vijay M. Rao, Md
Value-Added Services Of Hospital-Based Radiology Groups, Vijay M. Rao, Md
Department of Radiology Faculty Papers
Presentation at 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).
16 slides.
Department Of Radiology-Annual Executive Summary Report-July 1, 2010 To June 30, 2011, Vijay M. Rao, Md
Department Of Radiology-Annual Executive Summary Report-July 1, 2010 To June 30, 2011, Vijay M. Rao, Md
Department of Radiology Administrative Documents and Reports
90 page Department of Radiology Annual Executive Summary Report, July 1, 2010 to June 30, 2011, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Tables of Contents:
Department of Radiology
Chairman, Vice Chairmen 1
Divisions and Directors 1
Committees and Chairmen 1
Radiology Department Faculty Rank 2
Faculty with Secondary Appointments 3
Clinical Divisions 4
Radiology Residents and Fellows 5
Department Organizational Chart 6
Department Administration Chart 7
State of the Department 8
Appendix I: Publications Journal Articles 22
Books and Book Chapters 30
Abstracts 33
Appendix II: Formal Scientific Presentations 44
Appendix III: Honors, Editorial Activities, Service to Regional …
Religious Experiences Shrink Part Of The Brain, Andrew Newberg, M.D.
Religious Experiences Shrink Part Of The Brain, Andrew Newberg, M.D.
Marcus Institute of Integrative Health Faculty Papers
A study links life-changing religious experiences, like being born again, with atrophy in the hippocampus.
The article, “Religious factors and hippocampal atrophy in late life,” by Amy Owen and colleagues at Duke University represents an important advance in our growing understanding of the relationship between the brain and religion. The study showed greater atrophy in the hippocampus in individuals who identify with specific religious groups as well as those with no religious affiliation. It is a surprising result, given that many prior studies have shown religion to have potentially beneficial effects on brain function, anxiety, and depression.
Multiple Courses Of Stereotactic Re-Irradiation In Recurrent Oligodendroglioma: A Case Report., Shannon Fogh, Charles Glass, David W Andrews, Maria Werner-Wasik
Multiple Courses Of Stereotactic Re-Irradiation In Recurrent Oligodendroglioma: A Case Report., Shannon Fogh, Charles Glass, David W Andrews, Maria Werner-Wasik
Department of Radiation Oncology Faculty Papers
INTRODUCTION: High grade gliomas are an insidious disease associated with an extremely poor prognosis. The role of re-irradiation for recurrent gliomas is unclear but several retrospective studies have indicated mild toxicity and modest outcomes with this regimen. With subsequent progression, it is unclear what options remain and more radiotherapy is rarely offered for fear of surpassing normal central nervous system tissue tolerance and causing significant side effects without significant benefit.
CASE PRESENTATION: In this report, we describe a 37-year-old Caucasian male initially diagnosed with a grade IV oligodendroglioma, who received multiple courses of re-irradiation and experienced a survival of 10 …
Diagnosis Of Coronary Stenosis With Ct Angiography Comparison Of Automated Computer Diagnosis With Expert Readings., Ethan J Halpern, David J Halpern
Diagnosis Of Coronary Stenosis With Ct Angiography Comparison Of Automated Computer Diagnosis With Expert Readings., Ethan J Halpern, David J Halpern
Department of Radiology Faculty Papers
RATIONALE AND OBJECTIVES: To compare computer-generated interpretation of coronary computed tomography angiography (cCTA) by commercially available COR Analyzer software with expert human interpretation.
MATERIALS AND METHODS: This retrospective Health Insurance Portability and Accountability Act‑compliant study was approved by the institutional review board. Among 225 consecutive cCTA examinations, 207 were of adequate quality for automated evaluation. COR Analyzer interpretation was compared to human expert interpretation for detection of stenosis defined as ≥50% vessel diameter reduction in the left main, left anterior descending (LAD), circumflex (LCX), right coronary artery (RCA), or a branch vessel (diagonal, ramus, obtuse marginal, or posterior descending artery). …
Phase I Study Of 'Dose-Dense' Pemetrexed Plus Carboplatin/Radiotherapy For Locally Advanced Non-Small Cell Lung Carcinoma., Xinglei Shen, Albert Denittis, Maria Werner-Wasik, Rita Axelrod, Paul Gilman, Thomas Meyer, Joseph Treat, Walter J Curran, Mitchell Machtay
Phase I Study Of 'Dose-Dense' Pemetrexed Plus Carboplatin/Radiotherapy For Locally Advanced Non-Small Cell Lung Carcinoma., Xinglei Shen, Albert Denittis, Maria Werner-Wasik, Rita Axelrod, Paul Gilman, Thomas Meyer, Joseph Treat, Walter J Curran, Mitchell Machtay
Department of Radiation Oncology Faculty Papers
BACKGROUND: This phase I study investigates the feasibility of carboplatin plus dose-dense (q2-week) pemetrexed given concurrently with radiotherapy (XRT) for locally advanced and oligometastatic non-small cell lung cancer (NSCLC).
METHODS: Eligible patients had Stage III or IV (oligometastatic) NSCLC. Patients received XRT to 63 Gy in standard fractionation. Patients received concurrent carboplatin (AUC = 6) during weeks 1 and 5 of XRT, and pemetrexed during weeks 1, 3, 5, and 7 of XRT. The starting dose level (level 1) of pemetrexed was 300 mg/m2. Following the finding of dose limiting toxicity (DLT) in dose level 1, an amended dose level …